• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. MERIDIAN FILTER SYSTEM - JUGULAR; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. MERIDIAN FILTER SYSTEM - JUGULAR; VENA CAVA FILTER Back to Search Results
Catalog Number MD800J
Device Problems Malposition of Device (2616); Patient-Device Incompatibility (2682); Migration (4003)
Patient Problem Abdominal Pain (1685)
Event Date 11/19/2018
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process, and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.The medical records included images.The image review was documented in the medical records.Medical records were provided and reviewed.Approximately, two years and four days of post deployment, a computed tomography abdomen and pelvis was performed on patient reportedly experiencing abdominal pain.Findings noted minimal pleural effusions were present bilaterally and minimal infiltration posterior basilar region.Filter in the infra renal inferior vena cava was noted.Around, four years and four months later, a standard computed tomography was performed, demonstrating positive evidence of caval perforation with 9 o¿clock inferior strut of grade 2 perforation measuring at 3.7mm, 7 o¿clock inferior strut perforation measuring 3.6mm, and proximal struts with a grade 1 relation to the caval wall consistent with tenting.Filter was noted with posterior tilt measuring 17.66 degrees, 6-degree tilt to the left on the coronal images and a 6-degree tilt anteriorly on the sagittal images.All the struts of the filter protruded through the walls of the inferior vena cava into the surrounding adjacent tissues consistent with grade 2 perforations of the majority of the struts.The 2 anterior struts abutted the posterior wall of the duodenum, suggesting grade 2 or possibly grade 3 perforations.No involvement of the aorta was appreciated.Evidence of migration was also noted with the superior tip of the inferior vena cava was at the level of the renal veins.The upper tip of the filter ended at the upper level just below the level of the renal veins.No obvious clot is seen within the inferior vena cava without contrast.Therefore, the investigation is confirmed for the perforation of the inferior vena cava (ivc), filter tilt and filter migration.Based on the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(expiry date: 02/2013).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism.At some time post filter deployment, it was alleged that the filter perforated the inferior vena cava.The device has not been removed and there were no reported attempts made to retrieve the filter.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MERIDIAN FILTER SYSTEM - JUGULAR
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key12382013
MDR Text Key268629352
Report Number2020394-2021-80708
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K102511
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 08/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/30/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMD800J
Device Lot NumberGFWA4190
Was Device Available for Evaluation? No
Date Manufacturer Received08/03/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/09/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BUSPIRONE, AMITRIPTYLINE, IMITREX, FLUOXETINE; COUMADIN, LORTAB, CIPROFLOXACIN-CIPROFLOX HCL; CYANOCOBALAMIN, AND WARFARIN; HYDROCODONE, FIORICET, TOPAMAX, GEODON
Patient Outcome(s) Other;
Patient Age51 YR
Patient Weight94
-
-